1. Market Research
  2. > Biopharmaceutical Market Trends
  3. > Factor IX Industry

Factor IX Industry Statistics

You might be interested in: Therapy, Blood Disease, Hospital, Pharmaceutical, Blood Supply, Biopharmaceutical, Factor VIII, Biosimilar.

1-10 of about 900 reports for Factor IX

Blood Disease Statistics

  • January 2017
    104 pages
  • Blood Disease  

    Hospital  

    Therapy  

View report >

Blood Disease Statistics

  • May 2018
    160 pages
  • Blood Disease  

    Chronic Pain  

    Mental Health  

View report >

Blood Disease Statistics

  • January 2017
    4 pages
  • Blood Disease  

    Factor IX  

    Hospital  

View report >

Baxalta Incorporated - Analyst Report, 2016

  • January 2016
    262 pages
  • Therapy  

  • United States  

View report >

Baxalta Incorporated - Analyst Report, 2016

  • January 2016
    295 pages
  • Therapy  

  • United States  

View report >

Baxalta Incorporated - Analyst Report, 2016

  • January 2016
    253 pages
  • Therapy  

  • United States  

View report >

Baxalta Incorporated - Analyst Report, 2016

  • January 2016
    261 pages
  • Therapy  

  • United States  

View report >

Baxalta Incorporated - Annual Report, 2016

  • January 2016
    253 pages
  • Therapy  

  • United States  

View report >

Spark Therapeutics - Annual Report, February 2017

  • February 2017
    132 pages
  • Therapy  

  • United States  

View report >
5 reports for Factor IX

Purchase Reports From Reputable Market Research Publishers
(From $ 1100 - $ 2670)

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

  • $ 4995
  • Industry report
  • November 2017
  • by GBI Research

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor TherapySummaryHemophilia ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on